Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma β-cells: A molecular and binding characterization

European Journal of Pharmacology

Volumn 568, Issue 1-3, 2007, Pages 54-60

  Lugo Garcia, Laura ^a   Filhol, Romain ^a   Lajoix, Anne Dominique ^a   Gross, René ^a   Petit, Pierre ^a   Vignon, Jacques ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

ATP 35S binding; Diabetes; INS 1 cells; Purinergic P2Y receptor subtypes

Indexed keywords

2 (METHYLTHIO)ADENOSINE 5' DIPHOSPHATE; 2 (METHYLTHIO)ADENOSINE 5' MONOPHOSPHATE; 2 (METHYLTHIO)ADENOSINE 5' TRIPHOSPHATE; ADENOSINE 5' O (1 THIOTRIPHOSPHATE); ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; GLUCOSE; INSULIN; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG SELECTIVITY; GENE EXPRESSION; HOMOGENATE; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; WESTERN BLOTTING;

ADENOSINE DIPHOSPHATE; ANIMALS; CELL LINE, TUMOR; INSULIN-SECRETING CELLS; INSULINOMA; PROTEIN BINDING; RATS; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; THIONUCLEOTIDES;

EID: 34250860700     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.04.012     Document Type: Article

References (32)

1. Asfari M., Janjic D., Meda P., Li G., Halban P.A., and Wollheim C.B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130 (1992) 167-178
2. Burnstock G., and Knight G.E. Cellular distribution and function of P2 receptors subtypes in different systems. Int. Rev. Cytol. 240 (2004) 31-304
3. Candela R.J.L., and Garcia-Fernandez M.C. Stimulation of secretion of Insulin by adenosine-triphosphate. Nature 197 (1963) 1210
4. Chapal J., and Loubatières-Mariani M.M. Effects of phosphate-modified adenine nucleotide analogues on insulin secretion from perfused rat pancreas. Br. J. Pharmacol. 73 (1981) 105-110
5. Chevassus H., Roig A., Belloc C., Lajoix A.D., Broca C., Manteghetti M., and Petit P. P2Y receptor activation enhances insulin release from pancreatic beta-cells by triggering the cyclic AMP/protein kinase A pathway. Naunyn-Schmiedeberg's Arch. Pharmacol. 366 (2002) 464-469
6. Coutinho-Silva R., Parsons M., Robson T., and Burnstock G. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing. Cell Tissue Res. 306 (2001) 373-383
7. Coutinho-Silva R., Parsons R., Robson T., Lincoln J., and Burnstock G. P2X and P2Y purinoreceptor expression in pancreas from streptozotocin-diabetic rats. Mol. Cell. Endocrinol. 204 (2003) 141-154
8. Doyle M.E., and Egan J.M. Pharmacological agents that directly modulate insulin secretion. Pharmacol. Rev. 55 (2003) 105-133
9. Farret A., Vignaud M., Dietz S., Vignon J., Petit P., and Gross R. P2Y purinergic potentiation of glucose-induced insulin secretion and pancreatic β-cell metabolism. Diabetes 53 Suppl 3 (2004) S63-S66
10. Farret A., Filhol R., Linck N., Mentghetti M., Vignon J., Gross R., and Petit P. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5′-O-(1-boranotriphosphate)-adenosine analogues. Pharm. Res. 23 (2006) 2665-2671
11. Fischer B., Chulkin A., Boyer J.L., Harden K.T., Gendron F.P., Beaudoin A.R., Chapal J., Hillaire-Buys D., and Petit P. 2-Thioether 5′-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors. J. Med. Chem. 42 (1999) 3636-3646
12. Henquin J.C., Ravier M.A., Nenquin M., Jonas J.C., and Gilon P. Hierarchy of the β-cell signals controlling insulin secretion. Eur. J. Clin. Invest. 33 (2003) 742-750
13. Hillaire-Buys D., Shahar L., Fischer B., Chulkin A., Linck N., Chapal J., Loubatières-Mariani M.M., and Petit P. Pharmacological evaluation and chemical stability of 2-benzylthioether-5′-O-(1-thiotriphosphate)-adenosine, a new insulin secretagogue acting through P2Y receptors. Drug Dev. Res. 53 (2001) 33-43
14. Hollopeter G., Jantzen H.M., Vincent D., Li G., England L., Ramakrishnan V., Yang R.B., Nurden P., Nurden A., Julius D., and Conley P.B. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409 (2001) 202-207
15. Janjic D., Maechler P., Sekine N., Bartley C., Annen A.S., and Wollheim C.B. Free radical modulation of insulin release in INS-1 cells exposed to alloxan. Biochem. Pharmacol. 57 (1999) 639-648
16. Jantzen H.M., Gousset L., Bhaskar V., Vincent D., Tai A., Reynolds E.E., and Conley P.B. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb. Haemost. 81 (1999) 111-117
17. Leitner J.W., Sussman K.E., Vatter A.E., and Schneider F.H. Adenine nucleotides in the secretory granule fraction of rat islets. Endocrinology 96 (1975) 662-667
18. 1 receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic Signal. 1 (2005) 145-151
19. Loubatières-Mariani M.M., Chapal J., Lignon F., and Valette G. Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur. J. Pharmacol. 59 (1979) 277-286
20. Nahum V., Zundorf G., Levesque S.A., Beaudouin A.R., Reiser G., and Fischer B. Adenosine 5′-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonist. J. Med. Chem. 45 (2002) 5384-5396
21. Nakata H., Yoshioka K., Kamiya T., Tsuga H., and Oyanagi K. Functions of heteromeric association between adenosine and P2Y receptors. J. Mol. Neurosci. 26 2-3 (2005) 233-238
22. Obermüller S., Lindqvist A., Karanauskaite J., Galvanovskis J., Rorsman P., and Barg S. Selective nucleotide-release from dense-core granules in insulin-secreting cells. J. Cell Sci. 118 (2005) 4271-7282
23. Peinnequin A., Mouret C., Birot O., Alonso A., Mathieu J., Clarençon D., Agay D., Chancerelle Y., and Multon E. Rat pro-inflammatory cytokines and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 5 (2004) 3
24. Petit P., Bertrand G., Schmeer W., and Henquin J.C. Effects of extracellular adenine nucleotides on the electrical, ionic and secretory events in mouse pancreatic B-cells. Br. J. Pharmacol. 98 (1989) 875-882
25. Petit P., Hillaire-Buys D., Manteghetti M., Debrus S., Chapal J., and Loubatières-Mariani M.M. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell. Br. J. Pharmacol. 125 (1998) 1368-1374
26. Petit P., Hillaire-Buys D., Loubatières-Mariani M.M., and Chapal J. Purinergic receptors and the pharmacology of type 2 diabetes. In: Abbrachio M.P., and Williams M. (Eds). Handbook of Experimental Pharmacology: "Purinergic and Pyrimidinergic Signaling" (2001), Springer-Verlag, Berlin Heidelberg 377-391
27. Poulsen C.R., Bokvist K., Olsen H.L., Hoy M., Capito K., Gilon P., and Gromada J. Multiple sites of purinergic control of insulin secretion in mouse pancreatic β-cells. Diabetes 48 (1999) 2171-2181
28. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
29. 12 receptor oligomers and partitions them out of lipid rafts. Proc. Natl. Acad. Sci. 103 (2006) 11069-11074
30. Straub S.G., and Sharp G.W. Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes Metab. Res. Rev. 18 (2002) 451-463
31. 2Y purinoreceptors. Biochem. Biophys. Res. Commun. 211 (1995) 211-218
32. Verspohl E.J., Johanwille B., Waheed A., and Neye H. Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets. Can. J. Physiol. 80 (2002) 562-568